Top compounds associated with response to TNFRSF10C


Feature Type Standardized
Nominal ANOVA
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.062 0.04
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.066 0.04
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.064 0.04
mRNA AZD0530 CCLE pan-cancer AAC -0.094 0.04
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.04
mRNA Crizotinib CCLE pan-cancer AAC 0.091 0.04
mRNA barasertib CTRPv2 pan-cancer AAC -0.065 0.04
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.098 0.04
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.04
mRNA decitabine CTRPv2 pan-cancer AAC -0.055 0.04
Download CSV